cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues*
暂无分享,去创建一个
Ming-Chang Chiang | Yijuang Chern | M. Chiang | Y. Chern | Yi-Chao Lee | Yi-Chao Lee | Chuen-Lin Huang | Chuen‐Lin Huang
[1] D. Ginty,et al. Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. , 1991, The Journal of biological chemistry.
[2] U. Ungerstedt,et al. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] M. Jacobson,et al. Adenosine A2a receptor activation delays apoptosis in human neutrophils. , 1997, Journal of immunology.
[4] N. Nukina,et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.
[5] Peter Breuer,et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.
[6] K. Varani,et al. The FASEB Journal express article 10.1096/fj.00-0730fje. Published online March 5, 2001. Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin , 2022 .
[7] Y. Chern,et al. Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response* , 1997, The Journal of Biological Chemistry.
[8] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[9] D. Housman,et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Schiffmann,et al. A Dual Role of Adenosine A2A Receptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2A Antagonists , 2003, The Journal of Neuroscience.
[11] D. Rubinsztein,et al. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. , 2003, Human molecular genetics.
[12] He Li,et al. Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.
[13] K. Varani,et al. Aberrant A2A receptor function in peripheral blood cells in Huntington's disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] L. Farrell,et al. Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation , 2003, Molecular and Cellular Neuroscience.
[15] J. Kiang,et al. Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells , 2004, Molecular and Cellular Biochemistry.
[16] Y. Chern,et al. Identification of nuclear factor 1 (NF1) as a transcriptional modulator of rat A(2A) adenosine receptor. , 2003, Brain research. Molecular brain research.
[17] E. Schwarz,et al. CREB Cooperates with BMP‐stimulated Smad signaling to enhance transcription of the Smad6 promoter , 2004, Journal of cellular physiology.
[18] M. Dragunow,et al. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease , 2000, Neuroscience.
[19] Y. Chern,et al. Characterization of the rat A2a adenosine receptor gene. , 1996, DNA and cell biology.
[20] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[21] C. Ross,et al. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. , 2003, Human molecular genetics.
[22] Y. Chern,et al. The 5' Untranslated Regions of the Rat A2A Adenosine Receptor Gene Function as Negative Translational Regulators , 1999, Journal of neurochemistry.
[23] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[24] Ruth Luthi-Carter,et al. Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.
[25] Y. Chern,et al. Molecular cloning of a novel adenosine receptor gene from rat brain. , 1992, Biochemical and biophysical research communications.
[26] Andrea Crotti,et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.
[27] J. Olson,et al. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. , 2002, Human molecular genetics.
[28] Y. Chern,et al. Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells* , 2001, The Journal of Biological Chemistry.
[29] C. Vinson,et al. PTHrP Modulates Chondrocyte Differentiation through AP-1 and CREB Signaling* , 2001, The Journal of Biological Chemistry.
[30] R. Ferrante,et al. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3‐nitropropionic acid‐induced striatal damage , 2003, Journal of neurochemistry.
[31] C A Ross,et al. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.
[32] Y. Chern,et al. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.
[33] D. Rubinsztein,et al. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. , 2001, Human molecular genetics.
[34] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[35] J. Cha,et al. Transcriptional dysregulation in Huntington’s disease , 2000, Trends in Neurosciences.
[36] M. Caporali,et al. CGS 21680 antagonizes motor hyperactivity in a rat model of Huntington's disease. , 1994, European journal of pharmacology.
[37] J. Nevins,et al. Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription* , 2002, The Journal of Biological Chemistry.
[38] D. Rubinsztein,et al. Decreased cAMP Response Element-mediated Transcription , 2004, Journal of Biological Chemistry.
[39] M. Falchi,et al. Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum , 2002, The Journal of Neuroscience.
[40] J. Olson,et al. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. , 2002, Human molecular genetics.
[41] M. Umemiya,et al. A Calcium-Dependent Feedback Mechanism Participates in Shaping Single NMDA Miniature EPSCs , 2001, The Journal of Neuroscience.
[42] Wolfgang Schmid,et al. Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.
[43] Changyuan Huang,et al. CREB Is One Component of the Binding Complex of the Ces-2/E2A-HLF Binding Element and Is an Integral Part of the Interleukin-3 Survival Signal , 2001, Molecular and Cellular Biology.
[44] M. Chiang,et al. Characterization of the rat A2A adenosine receptor gene: a 4.8‐kb promoter‐proximal DNA fragment confers selective expression in the central nervous system , 2003, The European journal of neuroscience.
[45] Dimitri Krainc,et al. Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.
[46] D. Weaver. A2a adenosine receptor gene expression in developing rat brain. , 1993, Brain research. Molecular brain research.